Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation.

Aerts, Hugo J W L

Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: a prospective validation. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Jan 2012 - 73-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1872-8332

10.1016/j.lungcan.2011.06.003 doi


Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Non-Small-Cell Lung--diagnostic imaging
Chemoradiotherapy--methods
Cisplatin--administration & dosage
Deoxycytidine--administration & dosage
Fluorodeoxyglucose F18--pharmacokinetics
Humans
Lung Neoplasms--diagnostic imaging
Middle Aged
Positron-Emission Tomography--methods
Prospective Studies
Radiopharmaceuticals--pharmacokinetics
Radiotherapy Planning, Computer-Assisted
Tomography, X-Ray Computed--methods
Tumor Burden--radiation effects
Gemcitabine